Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/jac/dks286PMID 22872448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stepwise surface tailoring of carbon nanotubes with polyelectrolyte brushes and lipid layers to control their intracellular distribution and ``in vitro'' toxicity

  2011cited by this paper
• Recent advances in leishmaniasis treatment.

  2011cited by this paper
• Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis

  2011cited by this paper
• Targeted Liposomal Drug Delivery to Monocytes and Macrophages

  2010cited by this paper
• Emerging trend in nano-engineered polyelectrolyte-based surrogate carriers for delivery of bioactives

  2010cited by this paper
• Uptake of Biodegradable Gel-Assisted LBL Nanomatrix by Leishmania donovani-Infected Macrophages

  2009cited by this paper
• Drug delivery systems against leishmaniasis? Still an open question.

  2008cited by this paper
• Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections.

  2008cited by this paper
• Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods.

  2007cited by this paper
• BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module

  2007cited by this paper
• Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide.

  2007cited by this paper
• Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles.

  2007cited by this paper
• Engulfment of apoptotic cells: signals for a good meal

  2007cited by this paper
• Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.

  2006cited by this paper
• Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs.

  2006cited by this paper
• Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens1

  2006cited by this paper
• Formation and stability of paraffin oil-in-water nano-emulsions prepared by the emulsion inversion point method.

  2006cited by this paper
• Protamine sulfate causes endothelium-indepen-dent vasorelaxation via inducible nitric oxide syn-thase pathway

  2006cited by this paper
• Phosphatidylserine recognition by phagocytes: a view to a kill.

  2006cited by this paper
• Le sulfate de protamine cause un vasorelâchement indépendant de ľendothélium par la voie de ľoxyde nitrique synthase inductible

  2006cited by this paper
• IMPACT OF ENDOTOXIN-INDUCED CHANGES IN P-GLYCOPROTEIN EXPRESSION ON DISPOSITION OF DOXORUBICIN IN MICE

  2005cited by this paper
• Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models

  2005cited by this paper
• Matrix metalloproteinase–activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity

  2005cited by this paper
• Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine.

  2004cited by this paper
• Matrix polyelectrolyte microcapsules: new system for macromolecule encapsulation.

  2004cited by this paper
• Treatment of Experimental Visceral Leishmaniasis with Amphotericin B in Stable Albumin Microspheres

  2004cited by this paper
• Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells

  2003cited by this paper
• Liposomal doxorubicin.

  2002cited by this paper
• Advances in the treatment of leishmaniasis

  2002cited by this paper
• Identification of a factor that links apoptotic cells to phagocytes

  2002cited by this paper
• Stimulation of various functions in murine peritoneal macrophages by high mannuronic acid-containing alginate (HMA) exposure in vivo.

  2001cited by this paper
• Lipid Coating on Polyelectrolyte Surface Modified Colloidal Particles and Polyelectrolyte Capsules

  2000cited by this paper
• Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.

  2000cited by this paper
• Electrokinetic properties of spontaneously precipitated calcium carbonate polymorphs: the influence of organic substances

  2000cited by this paper
• Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance.

  2000cited by this paper
• Synergistic effect of interferon-gamma and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis.

  1999cited by this paper
• Leishmania donovani: cellular and humoral immune responses in Indian langur monkeys, Presbytis entellus.

  1999cited by this paper
• High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues.

  1999cited by this paper
• Factors Controlling the Growth of Polyelectrolyte Multilayers

  1999cited by this paper
• Layer-by-layer assembled multicomposite films.

  1998cited by this paper
• Stepwise Polyelectrolyte Assembly on Particle Surfaces: a Novel Approach to Colloid Design

  1998cited by this paper
• Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG

  1998cited by this paper
• The role of phosphatidylserine in recognition of apoptotic cells by phagocytes

  1998cited by this paper
• Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites

  1997cited by this paper
• Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity.

  1997cited by this paper
• Identification of the Product of Growth Arrest-specific Gene 6 as a Common Ligand for Axl, Sky, and Mer Receptor Tyrosine Kinases*

  1996cited by this paper
• Liposomal doxorubicin.

  1996cited by this paper
• The Class B Scavenger Receptors SR-BI and CD36 Are Receptors for Anionic Phospholipids (*)

  1995cited by this paper
• A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.

  1995cited by this paper
• Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.

  1994cited by this paper
• Potential of doxorubicin as an antileishmanial agent.

  1992cited by this paper
• Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.

  1992cited by this paper
• Leishmania donovani in hamsters: Stimulation of non-specific resistance by some novel glycopeptides and impact on therapeutic efficacy

  1991cited by this paper
• Drug targeting in Leishmania donovani infections using tuftsin‐bearing liposomes as drug vehicles

  1989cited by this paper
• Internalization of phosphatidylserine by adherent and non-adherent rat mononuclear cells.

  1989cited by this paper
• A prospective study of visceral leishmaniasis in an endemic area of Brazil.

  1986cited by this paper
• Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes.

  1984cited by this paper
• The experimental chemotherapy of leishmaniasis, IV. The development of a rodent model for visceral infection.

  1980cited by this paper
• Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.

  1980cited by this paper
• The experimental chemotherapy of leishmaniasis. II. The activity in tissue culture of some antiparasitic and antimicrobial compounds in clinical use.

  1975cited by this paper

• MMP-Sensitive Macrophage-Targeted Coenzyme Q10 Nanomedicine for Rheumatoid Arthritis Treatment

  2025cites this paper
• Anti-leishmanial therapies: overcoming current challenges with emerging therapies

  2024influential citation
• Nanoparticles for the treatment of visceral leishmaniasis: review

  2023influential citation
• The Implications of Microglial Regulation in Neuroplasticity-Dependent Stroke Recovery

  2023cites this paper
• Damage mechanisms of sludge flocs and cell structures by different pretreatment methods

  2023cites this paper
• Antileishmanial potential of species from the family Lamiaceae: chemical and biological aspects of non-volatile compounds.

  2022cites this paper
• Upcycling the anthracyclines: New mechanisms of action, toxicology, and pharmacology.

  2022cites this paper
• Edible plant-derived nanotherapeutics and nanocarriers: recent progress and future directions

  2022cites this paper
• The role of phosphatidylserine on the membrane in immunity and blood coagulation

  2022cites this paper
• Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis - A review.

  2021cites this paper
• ‘Sweet as a Nut’: Production and Use of Nanocapsules made of Glycopolymer or Polysaccharide shell

  2021cites this paper
• Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis

  2021cites this paper
• Nanotechnology-aided Diagnosis, Treatment and Prevention of Leishmaniasis.

  2021cites this paper
• Chalcone-rich extracts from Lonchocarpus cultratus roots present in vitro leishmanicidal and immunomodulatory activity.

  2021cites this paper
• Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight

  2021cites this paper
• Curcumin loaded drug delivery systems in the treatment of liver diseases

  2021cites this paper
• The advantages of nanomedicine in the treatment of visceral leishmaniasis: between sound arguments and wishful thinking

  2020cites this paper
• Combination therapy with amphotericin B and doxorubicin encapsulated in mannosylated nanomicelles for visceral leishmaniasis

  2020cites this paper
• Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities

  2020cites this paper
• Brinzolamide loaded core-shell nanoparticles for enhanced coronial penetration in the treatment of glaucoma

  2020cites this paper
• Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development

  2019cites this paper
• Anti-leishmanial Nanotherapeutics: A Current Perspective.

  2019cites this paper
• Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application.

  2019cites this paper
• Doxorubicin-Immersed Skeletal Muscle Grafts Promote Peripheral Nerve Regeneration Across a 10-mm Defect in the Rat Sciatic Nerve

  2019cites this paper
• Erratum: Doxorubicin-Immersed Skeletal Muscle Grafts Promote Peripheral Nerve Regeneration Across a 10-mm Defect in the Rat Sciatic Nerve

  2019cites this paper
• Nanoemulsion: A brief review on development and application in Parenteral Drug Delivery

  2018cites this paper
• Fabrication of 3-O-sn-Phosphatidyl-L-serine Anchored PLGA Nanoparticle Bearing Amphotericin B for Macrophage Targeting

  2018cites this paper
• Crossing Biological Barriers for Leishmaniasis Therapy: From Nanomedicinal Targeting Perspective

  2018influential citation
• Enhanced efficacy of curcumin with phosphatidylserine-decorated nanoparticles in the treatment of hepatic fibrosis

  2017cites this paper
• Nanotechnological Strategies for Treatment of Leishmaniasis--A Review.

  2017cites this paper
• Redox biology of Leishmania and macrophage targeted nanoparticles for therapy.

  2017cites this paper
• PEGylated Dendritic Polyglycerol Conjugate Delivers Doxorubicin to the Parasitophorous Vacuole in Leishmania infantum Infections.

  2017cites this paper
• Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis.

  2017cites this paper
• Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis.

  2017cites this paper
• Nanostructured delivery systems with improved leishmanicidal activity: a critical review

  2017cites this paper
• Nanoarchitectures for Neglected Tropical Protozoal Diseases: Challenges and State of the Art

  2017cites this paper
• Nanoemulsion: Concepts, development and applications in drug delivery

  2017cites this paper
• Click Biotinylation of PLGA Template for Biotin Receptor Oriented Delivery of Doxorubicin Hydrochloride in 4T1 Cell-Induced Breast Cancer.

  2017cites this paper
• Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B

  2016cites this paper
• Enhancement of Anti-Inflammatory Activity of Curcumin Using Phosphatidylserine-Containing Nanoparticles in Cultured Macrophages

  2016influential citation
• Twin Attributes of Tyrosyl-tRNA Synthetase of Leishmania donovani

  2016cites this paper
• New approaches from nanomedicine for treating leishmaniasis.

  2016cites this paper
• Cytotoxicity and Genotoxicity in Human Embryonic Kidney Cells Exposed to Surface Modify Chitosan Nanoparticles Loaded with Curcumin

  2016cites this paper
• Macrophage-targeted chitosan anchored PLGA nanoparticles bearing doxorubicin and amphotericin B against visceral leishmaniasis

  2016cites this paper
• Phosphatidylserine-modified curcumin nanoparticles

  2016cites this paper
• MACROPHAGE TARGETING: A STRATEGY FOR LEISHMANIASIS SPECIFIC DELIVERY

  2016cites this paper
• Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis

  2015cites this paper
• Development of 4-sulfated N-acetyl galactosamine anchored chitosan nanoparticles: A dual strategy for effective management of Leishmaniasis.

  2015cites this paper
• Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies.

  2015cites this paper
• Investigational drugs for visceral leishmaniasis

  2015cites this paper
• Nanomedical Therapeutic and Prophylaxis Strategies Against Intracellular Protozoa in the Americas

  2015cites this paper
• Liposomal Formulation of Turmerone-Rich Hexane Fractions from Curcuma longa Enhances Their Antileishmanial Activity

  2014cites this paper
• Dendronized nanoconjugates of lysine and folate for treatment of cancer.

  2014cites this paper
• Nanotechnology and the diagnosis/treatment of leishmaniasis.

  2014cites this paper
• Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation.

  2014cites this paper
• Drug delivery: lessons to be learnt from Leishmania studies.

  2014cites this paper
• Coating doxorubicin‐loaded nanocapsules with alginate enhances therapeutic efficacy against Leishmania in hamsters by inducing Th1‐type immune responses

  2014cites this paper
• Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies

  2014cites this paper
• Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies

  2014cites this paper
• Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis

  2014cites this paper
• Direct recognition of superparamagnetic nanocrystals by macrophage scavenger receptor SR-AI.

  2013cites this paper
• Chitosan-dextran sulphate nanocapsule drug delivery system as an effective therapeutic against intraphagosomal pathogen Salmonella.

  2013cites this paper
• Colon-specific delivery of curcumin by exploiting Eudragit-decorated chitosan nanoparticles in vitro and in vivo

  2013cites this paper
• Exploiting 4-sulphate N-acetyl galactosamine decorated gelatin nanoparticles for effective targeting to professional phagocytes in vitro and in vivo

  2012cites this paper